179 related articles for article (PubMed ID: 22965634)
21. [Surveillance of patients with Barrett's esophagus].
Endlicher E; Knüchel R; Messmann H
Z Gastroenterol; 2001 Aug; 39(8):593-600. PubMed ID: 11558064
[TBL] [Abstract][Full Text] [Related]
22. Gastric fluid bile concentrations and risk of Barrett's esophagus.
Nason KS; Farrow DC; Haigh G; Lee SP; Bronner MP; Rosen SN; Vaughan TL
Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):304-7. PubMed ID: 17669852
[TBL] [Abstract][Full Text] [Related]
23. Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas.
Regalado SP; Nambu Y; Iannettoni MD; Orringer MB; Beer DG
Mol Carcinog; 1998 Jul; 22(3):182-9. PubMed ID: 9688144
[TBL] [Abstract][Full Text] [Related]
24. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells.
Huo X; Juergens S; Zhang X; Rezaei D; Yu C; Strauch ED; Wang JY; Cheng E; Meyer F; Wang DH; Zhang Q; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G278-86. PubMed ID: 21636532
[TBL] [Abstract][Full Text] [Related]
25. Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus.
Stairs DB; Nakagawa H; Klein-Szanto A; Mitchell SD; Silberg DG; Tobias JW; Lynch JP; Rustgi AK
PLoS One; 2008; 3(10):e3534. PubMed ID: 18953412
[TBL] [Abstract][Full Text] [Related]
26. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
[TBL] [Abstract][Full Text] [Related]
27. Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus.
Dvorak K; Chavarria M; Payne CM; Ramsey L; Crowley-Weber C; Dvorakova B; Dvorak B; Bernstein H; Holubec H; Sampliner RE; Bernstein C; Prasad A; Green SB; Garewal H
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5305-13. PubMed ID: 17875759
[TBL] [Abstract][Full Text] [Related]
28. Cancer risk in Barrett's oesophagus.
Dias Pereira A; Suspiro A; Chaves P
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
[TBL] [Abstract][Full Text] [Related]
29. Surgical management of Barrett's esophagus.
Clark GW; DeMeester TR
Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
[TBL] [Abstract][Full Text] [Related]
30. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
31. Deoxycholic acid at neutral and acid pH, is genotoxic to oesophageal cells through the induction of ROS: The potential role of anti-oxidants in Barrett's oesophagus.
Jenkins GJ; D'Souza FR; Suzen SH; Eltahir ZS; James SA; Parry JM; Griffiths PA; Baxter JN
Carcinogenesis; 2007 Jan; 28(1):136-42. PubMed ID: 16905748
[TBL] [Abstract][Full Text] [Related]
32. Barrett's esophagus.
Phillips WA; Lord RV; Nancarrow DJ; Watson DI; Whiteman DC
J Gastroenterol Hepatol; 2011 Apr; 26(4):639-48. PubMed ID: 21166712
[TBL] [Abstract][Full Text] [Related]
33. Gastroesophageal reflux disease and Barrett's esophagus.
Falk GW
Endoscopy; 2001 Feb; 33(2):109-18. PubMed ID: 11272213
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
Jankowski J; Hopwood D; Pringle R; Wormsley KG
Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
[TBL] [Abstract][Full Text] [Related]
35. Scanning electron microscopy of the human esophagus: application to Barrett's esophagus, a precancerous lesion.
Shields HM; Sawhney RA; Zwas F; Boch JA; Kim S; Goran D; Antonioli DA
Microsc Res Tech; 1995 Jun; 31(3):248-56. PubMed ID: 7670163
[TBL] [Abstract][Full Text] [Related]
36. Acid and bile salt up-regulate BMP4 expression in human esophageal epithelium cells.
Zhou G; Sun YG; Wang HB; Wang WQ; Wang XW; Fang DC
Scand J Gastroenterol; 2009; 44(8):926-32. PubMed ID: 19488929
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and treatment of Barrett's oesophagus. A general survey.
Petrakis IE; Sciacca V; Iascone C
Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
[TBL] [Abstract][Full Text] [Related]
38. [Barrett's esophagus].
Kouzu T; Yoshimura S; Onuma EK; Hishikawa E; Arima M
Nihon Geka Gakkai Zasshi; 1998 Sep; 99(9):552-7. PubMed ID: 9842539
[TBL] [Abstract][Full Text] [Related]
39. Barrett's esophagus and esophageal adenocarcinoma.
Reid BJ
Gastroenterol Clin North Am; 1991 Dec; 20(4):817-34. PubMed ID: 1787015
[TBL] [Abstract][Full Text] [Related]
40. In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma.
Morales CP; Lee EL; Shay JW
Cancer; 1998 Aug; 83(4):652-9. PubMed ID: 9708927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
